EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. (EYPT) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 311 transactions totaling $189.7M, demonstrating a bullish sentiment with $33.1M in net insider flow. The most recent transaction on Jan 5, 2026 involved a transaction of 29,250 shares valued at $0.
EYPT Insider Activity Summary
Who Is Buying EYPT Stock?
No significant insider buying has been recorded for EYPT in the recent period.
Who Is Selling EYPT Stock?
No significant insider selling has been recorded for EYPT in the recent period.
Is EyePoint Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EYPT is bullish with an Insider Alignment Score of 59/100 and a net flow of $33.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
EYPT Frequently Asked Questions
Understanding EYPT Insider Activity
Insider trading at EyePoint Pharmaceuticals, Inc. (EYPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading EYPT stock, having executed 311 transactions in the past 90 days. The most active insider is Ye Liu (Executive), who has made 4 transactions totaling $56.7M.
Related Tools
Track EyePoint Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at EYPT file new Form 4 transactions